Protecting people from mosquito-borne disease.
It is the poorest communities in Africa that are most affected by mosquito-borne disease. Until now an affordable, effective repellent was not available to them.
We decided to change that reality by distributing NO MO – a non-toxic repellent with exceptional efficacy – to countries where diseases like malaria and dengue cause thousands of deaths and preventable suffering to millions.
Support us in this effort:
“With personal repellents, I have never encountered anything that comes close to the performance of NOMO. In laboratory tests, it protects at least 9 hours. 100% protection. No biting, no probing, no landing.”
— Tony Kiszewski, ScD, Public Health Entomologist, Bentley University
Read Research, Articles, and Reports >>
NOMO repellent provides complete protection for 8-10 hours against disease transmitting mosquitos. It is a patented, non-toxic lotion, which when widely distributed, will be an effective disease reduction tool in regions with serious vector control problems.
Our goal is to distribute NO MO to communities in Africa where infectious diseases like malaria and dengue cause preventable suffering to millions.
Comprehensive field and laboratory studies have shown that NO MO is the most effective repellent for disease vectors that is currently available.
Working with scientists, public health leaders and donors, we can reduce deaths and suffering, foster healthy communities and enhance opportunities for economic growth in Africa. Learn how you can support our effort.
Stay in Touch.
Join our mailing list for new research, case studies & project updates.
A defensive shield against disease.
Insect-borne diseases like malaria kill hundreds of thousands
of people every year, and disable many millions more.
How can a simple but highly effective repellent
reduce this tremendous suffering?
THE NO MO PLAN
Our plan is to distribute NO MO on a not-for-profit basis in Africa. Licensing royalties and contributions from donors will ultimately support the repellent’s distribution below cost to disease-endemic countries there.
VIEW RESEARCH PAPERS
For 8 hours with no bites, NO MO was tested in a laboratory against a population of Colombian phlebotomine sand flies (Lutzomyia longpalpis).
The objective of the test was to determine the Complete Protection Time of NO MAS repellent (NO MO), when applied at a typical consumer dose, against wild populations of mosquitos in two different habitats.
NO MAS (NO MO) mosquito repellent was evaluated in two farming villages (4 km apart) in the Kassena Nankana district of northern Ghana. We determined its efficacy against local malaria vectors, degree of user acceptance, and its effect on malaria prevalence in households using insecticide-treated bed nets.
In order to estimate the epidemiological efficacy of mosquito repellents in communities, a static probability model is presented to simulate malaria infection during a single transmission season.
For 9 hours, a sample of NO MAS (NO MO), was cage-tested against a colony of 200 female Aedes aegypti mosquitoes that were pre-selected for avidity. With a minimum standard of >25 landings in 10 seconds on an untreated control arm, the test was conducted with a biting pressure that was orders of magnitude greater than in nature, and there were no bites.
In a field trial conducted by parasitologists with the University of Ghana, the efficacy of NO MAS (NO MO) was compared with DEET-based repellents against the notorious black fly (simulium damnosum), a vector for river blindness (onchocerciasis).